Moreover, treating tumor-bearing mice with agonistic anti-CD40 monoclonal antibodies, including clone FGK45, drives reeducation of TAMs toward an anti-tumorigenic phenotype and induces macrophage-dependent antitumor responses14–17. This evidence concerns the gene CD40 and neoplasm.